Overview
- 8 inspections across 8 sites are on record.
- 28 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-04-20.
At a glance
Inspections
8
Sites
8
Observations
28
Career since
Feb 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Nephron Sterile Compounding Center, LLC | 20 Apr 2022 | Human Drugs | View 483 → |
| Nephron SC, LLC | 20 Apr 2022 | Human Drugs | View 483 → |
| The Procter & Gamble Manufacturing Company | 18 Feb 2022 | Human Drugs | View 483 → |
| PharmAgra Labs Inc | 17 Nov 2021 | Human Drugs | |
| Coty US LLC | 27 Oct 2021 | Human Drugs | View 483 → |
Sites inspected
Nephron Sterile Compounding Center, LLCWest Columbia, United States1 insp.
Nephron SC, LLCWest Columbia, United States1 insp.
The Procter & Gamble Manufacturing CompanyBrowns Summit, United States1 insp.
PharmAgra Labs IncBrevard, United States1 insp.
Coty US LLCSanford, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Veronica Fuentes3 shared
Demario L Walls2 shared
Desiree D Clark2 shared
Saundrea A Munroe2 shared
Margaret M Annes2 shared
Brandon C Heitmeier2 shared
Ileana Barreto-Pettit1 shared
Full investigator report
Get the verbatim findings behind Kemejumaka N Opara's 28 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site